Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 12

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 12
---
TABLE OF CONTENTS

specific experience, qualifications, attributes and skills that led our Board of Directors to the conclusion that such individual should serve as a director in light of our business and structure.

Nominees for Election to Three Year Terms Expiring at the 2028 Annual Meeting of Stockholders

| Class I Director Nominees |     | Age |     | Director Since |     | Current Position at             
 Immuneering                     |
| Ann E. Berman             |     |  72 |     | July 2021      |     | Chair of the Board of Directors |
| Diana F. Hausman, M.D.    |     |  62 |     | January 2022   |     | Director                        |
| Thomas J. Schall, Ph.D.   |     |  65 |     | March 2024     |     | Director                        |

Ann E. Berman has served on our Board of Directors since July 2021 and as Chair of the Board since January 2024. She currently serves as a member of the board of directors of Loews Corporation, a position she has held since February 2006, and as Vice Chair of the board of trustees of Beth Israel Deaconess Medical Center, a position she has held since October 2019, where she is also the Chairwoman of its Compliance and Risk Committee. From September 2011 until June 2021, Ms. Berman served as a member of the board of directors and Chair of the Audit Committee of Cantel Medical Corp. In addition, she served as a member of the board of directors and Chair of the Audit Committee of Eaton Vance Corporation from February 2006 until March 2021, and as a member of the board of directors and Chair of the Audit Committee of Renalytix plc from July 2021 until September 2022. Prior to these roles, Ms. Berman served in various financial and risk management capacities at Harvard University, including as Senior Advisor to the President of Harvard University, Vice President of Finance and Chief Financial Officer. She received her B.A. with distinction in French language and literature from Cornell University, where she was Phi Beta Kappa, and her M.B.A. from the University of Pennsylvania’s Wharton School of Business. We believe that Ms. Berman is qualified to serve on our Board of Directors due to her accounting and financial management expertise as a Certified Public Accountant, experience as Chief Financial Officer of a major research university, service as an audit